Related Experiment Video
Updated: Aug 5, 2026

Rodent Model of Masseter Volumetric Muscle Loss for Studying Bioengineering Materials
Published on: May 31, 2024
Anatomical Rationale for Motor Endplate Zone-Targeted Botulinum Toxin Injection in the Masseter Muscle: A
1Department of Oral and Maxillofacial Surgery, National Hospital Organization, Kyoto Medical Center, 1-1 Mukaihata-cho, Fukakusa, Fushimi-ku, Kyoto 612-8555, Japan.
Targeting motor endplate zones (MEZs) for botulinum neurotoxin (BoNT) injections may improve masseter muscle treatment. This approach aims for efficient blockade with potentially lower doses, reducing adverse events in conditions like bruxism.
Area of Science:
- Neurology
- Anatomy
- Pharmacology
Background:
- Botulinum neurotoxin (BoNT) injections treat masseter muscle conditions like dystonia and bruxism.
- Current techniques lack standardization, leading to variable outcomes and adverse events.
Purpose of the Study:
- To review the anatomical and pharmacological basis for motor endplate zone (MEZ)-targeted BoNT injections in the masseter muscle.
- To propose MEZ targeting as a hypothesis for future research, not an established guideline.
Main Methods:
- Review of anatomical and electrophysiological studies on masseter neuromuscular junctions.
- Pharmacological considerations of BoNT delivery to MEZs.
Main Results:
- Neuromuscular junctions are concentrated in specific MEZs within the masseter muscle.
- MEZ-targeted delivery may enhance neuromuscular blockade efficiency and allow dose reduction.
Conclusions:
- MEZ targeting offers a theoretical framework for optimizing BoNT injections in the masseter.
- Further controlled studies are needed to validate this technique and assess its clinical benefits and safety profile.
More Related Videos
10:57Intramuscular Injections Along the Motor End Plates: A Minimally Invasive Approach to Shuttle Tracers Directly into Motor Neurons
Published on: July 13, 2015
06:46In Vivo Functional Assessment of Rat Masseter Muscle Following Surgical Creation of a Volumetric Muscle Loss (VML) Injury
Published on: November 15, 2024
Related Concept Videos
Neuromuscular Junction And Blockade
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
The binding of dantrolene to the RYR1...
Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Skeletal Muscle Relaxants: Therapeutic Uses
Depolarizing Blockers: Mechanism of Action
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because succinylcholine...
The Neuromuscular Junction